Publication | Open Access

Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: Need for agents to target antibody-secreting plasma cells

VaccinationImmunohematologyPompe DiseaseMaternal ImmunizationAutoimmune DiseaseAllergyImmunodeficienciesImmunologySerologic TestingAntibody ScreeningAutoimmunityAntibody-secreting Plasma CellsAntibody EngineeringImmunotherapyMedicineReplacement Therapy